---
title: "Trump’s FDA and NSF Picks Both Collapse in the Senate on the Same Day"
description: "Cassidy says one nominee had the votes and was pulled anyway, while the other was shelved for having none."
author: "Luis Goa"
published: 2026-11-18T22:08:57Z
modified: 2026-11-19T04:28:26Z
url: https://rews.cc/a/trump-s-fda-and-nsf-picks-both-collapse-in-the-senate-on-the-7c41ef
language: en
tags: ["trump", "fda", "nsf", "bureaucracy", "us"]
publisher: "Rews (https://rews.cc)"
---

# Trump’s FDA and NSF Picks Both Collapse in the Senate on the Same Day

*Cassidy says one nominee had the votes and was pulled anyway, while the other was shelved for having none.*

By Luis Goa · November 18, 2026 · https://rews.cc/a/trump-s-fda-and-nsf-picks-both-collapse-in-the-senate-on-the-7c41ef

## In brief

- White House withdrew FDA nominee Heidi Overton on Nov 17, a day before her Senate committee vote
- HELP Committee Chairman Bill Cassidy pulled the vote on NSF nominee Jim O’Neill the next morning without a formal vote
- Cassidy says Overton had the votes and blames unresolved abortion-pill commitments, not a vote shortage
- NSF’s entire 24-member governing board was fired in April 2026; Congress later rejected Trump’s proposed 57% funding cut
- Democrats will control the Senate 56-44 and the House by roughly 83 seats starting January 2027

Two Senate confirmation fights for federal science and health leadership collapsed within about 15 hours of each other, on Nov. 17 and 18. The White House withdrew Heidi Overton’s nomination to run the Food and Drug Administration a day before the Senate health committee was due to vote on her. The next morning, the same committee’s chairman pulled the vote on Jim O’Neill, Trump’s pick to run the National Science Foundation, without the White House ever withdrawing that nomination. Both agencies now run without Senate-confirmed leadership into 2027, as Ars Technica reported, in its own coverage, that the moment “requires leadership and fortitude.”

The arithmetic behind both outcomes is the same. The Senate Health, Education, Labor and Pensions Committee splits 12 Republicans to 11 Democrats, a 23-seat panel on which any Trump nominee needs all 12 Republican votes, since the 11 Democrats are assumed hostile by default. That one-vote margin is what killed O’Neill’s chances without a recorded vote at all: HELP chairman Bill Cassidy told Science that O’Neill “didn’t have the votes” and simply dropped his name from Wednesday’s business-meeting agenda, as Science reported. For Overton, the same one-vote margin produced the opposite claim: the chairman says she would have cleared it.

![A hand lifts one chair from a broken seesaw while another chair sits on the lower end against a red background.](https://rews.cc/img/095ebf0cb4a25860a9bc291e5760222be7a86bfc.webp)

## A nominee with the votes, pulled anyway

Trump nominated Overton, a preventive-medicine physician then serving as deputy director of the White House Domestic Policy Council, in August — three months after Marty Makary quit as FDA commissioner. Makary left in May after Trump overturned the agency’s ban on fruit-flavored vapes; Overton, at her September confirmation hearing, defended that reversal, telling the committee there was evidence flavored vapes help some adult smokers quit. Her nomination ran into trouble from several directions at once, [U.S. News reported, citing Reuters](https://www.usnews.com/news/politics/articles/2026-11-17/trump-withdraws-heidi-overton-as-nominee-to-lead-food-and-drug-administration-sources-say), and the White House told reporters it pulled her on Nov. 17 for lack of votes.

> The WH said that this was because she did not have the votes to pass. This was odd as I was having productive conversations with members. I believe she would have had the votes to pass out of committee and pass the full Senate.

Cassidy’s own account, posted to X and reported by [The Hill](https://thehill.com/policy/healthcare/6226487-white-house-withdraws-fda-nomination/), points to a different mechanism than a vote shortfall: anti-abortion senators withholding support until the administration committed to restrict the FDA’s mail-order dispensing of the abortion pill mifepristone. Susan B. Anthony Pro-Life America had publicly urged the committee to delay Overton’s vote on exactly that demand, even though Overton herself had previously criticized the Biden administration’s loosening of mifepristone dispensing rules. Asked to put a commitment on mifepristone in writing, the White House withdrew the nomination instead of making one.

**How the vote math worked against Overton** Senate HELP Committee, 12 R–11 D

| From | To | How |
| --- | --- | --- |
| HELP Committee, 12 R–11 D | Overton needs all 12 GOP votes |  |
| Overton needs all 12 GOP votes | Anti-abortion senators withhold support | 1 defection kills it |
| Anti-abortion senators withhold support | Demand FDA curb mail mifepristone *(Susan B. Anthony Pro-Life America)* |  |
| Demand FDA curb mail mifepristone *(Susan B. Anthony Pro-Life America)* | White House declines to commit |  |
| White House declines to commit | Nomination withdrawn, Nov. 17 |  |
| Nomination withdrawn, Nov. 17 | Cassidy disputes WH's vote-count claim |  |

![How the vote math worked against Overton. Senate HELP Committee, 12 R–11 D](https://rews.cc/img/28e132e5bf9c5eb6a2e1bde3e585d21fcb838308.webp)

Based on [Sen. Bill Cassidy's statement; The Hill](https://thehill.com/policy/healthcare/6226487-white-house-withdraws-fda-nomination/)

Whoever eventually runs the FDA inherits an agency that has lost roughly 4,500 staff over the past year, according to reporting cited by [U.S. News](https://www.usnews.com/news/politics/articles/2026-11-17/trump-withdraws-heidi-overton-as-nominee-to-lead-food-and-drug-administration-sources-say) — a toll that began with Health Secretary Robert F. Kennedy Jr.’s April 2025 layoff of 3,500 employees across HHS and grew through a Makary tenure that cost the agency career leaders, including former Oncology Center of Excellence director Richard Pazdur. Kyle Diamantas, a food-industry lawyer with no medical training who had been the FDA’s deputy commissioner for food, has run the agency as acting commissioner since May 15. Cassidy’s assessment of what comes next, from Ars Technica’s reporting: “Unfortunately, with the limited time left, confirming a permanent FDA Commissioner will fall to Senate Democrats.”

## A science agency without a board

O’Neill came to the NSF nomination from HHS, where he has served as deputy secretary, and from a stint as acting director of the Centers for Disease Control and Prevention — a job he took over after Susan Monarez was fired less than a month into her Senate-confirmed tenure. Before government, he was a Silicon Valley investor and a close ally of Peter Thiel, with no research-science background. Cassidy’s objection, delivered at Wednesday’s HELP business meeting, was that O’Neill failed the test that matters for the job.

> \[O’Neill\] did not do enough to stand up for science and against irresponsible decisions and statements from \[Health\] Secretary \[Robert F.\] Kennedy \[Jr.\].

Cassidy argued the NSF’s director needs real independence from the White House, and said, according to Science’s account of the closed-door session, that he doubted O’Neill would provide it — citing O’Neill’s role in Monarez’s firing as his evidence. Monarez told the same committee, in September 2025 testimony reported by [CBS News](https://www.cbsnews.com/live-updates/cdc-susan-monarez-debra-houry-senate-testimony-rfk-jr/), that Kennedy gave her an ultimatum weeks into the job: pre-approve new vaccine recommendations from his restructured advisory panel without reviewing the evidence, or be fired. She refused and was fired 29 days after confirmation; Kennedy and HHS dispute her account, saying she had “declared herself untrustworthy” and acted to undermine the president’s agenda. O’Neill ran the CDC in the interim.

![A microscope hangs from yellow strings attached to crossed control bars against a bright blue background.](https://rews.cc/img/96e99da6e58df924ad99e040fbe0d75354bcdece.webp)

The agency O’Neill would have run has absorbed a separate set of blows this year. On April 24, Trump fired all 24 members of the National Science Board — the body, created alongside NSF in 1950, that sets policy and approves the agency’s budget jointly with its director — without explanation, as [Al Jazeera reported](https://www.aljazeera.com/economy/2026/4/28/trump-administration-fires-all-members-of-us-national-science-board). AAAS chief executive Sudip Parikh called the move part of “a string of erratic decisions” destabilizing American science.

Trump’s own FY2026 budget request sought to cut NSF from $9.06 billion to $3.9 billion, a 57% reduction, as part of a $163 billion rollback in nondefense spending. Congress rejected nearly all of it: the appropriations package Trump signed in January funds NSF at $8.75 billion for fiscal 2026, a 3.4% cut, according to [AAAS’s analysis](https://www.aaas.org/sites/default/files/2026-02/Final%20Report%202026_0.pdf), with the reduction concentrated in STEM-education funding, cut 20%, while core research spending held flat at $7.18 billion. The agency still canceled or suspended 1,996 individual grants over 2025 on its own initiative, nearly 90% of them tied to diversity, equity and inclusion criteria, according to [the Urban Institute](https://www.urban.org/urban-wire/nsf-has-canceled-more-1500-grants-nearly-90-percent-were-related-dei), and halved its graduate research fellowship cohort to 1,000 awards, the smallest since 2010.

Former National Science Board members told reporters they feared the mass firing cleared the way for O’Neill to stack a replacement board with political allies — following the pattern Trump already set at the President’s Council of Advisors on Science and Technology, which, [as Ars Technica noted](https://arstechnica.com/health/2026/11/trump-abandons-his-fda-nominee-and-senate-scraps-vote-on-his-nsf-pick/), now runs on executives from Meta, Google, Oracle and Nvidia rather than working scientists.

## What January changes

Both vacancies now run into a hard deadline. Democrats swept the Nov. 3 midterms, flipping nine Senate seats for a 56-44 majority and winning a roughly 83-seat House majority, [CNBC reported](https://www.cnbc.com/2026/11/04/democrats-2026-midterm-election-results.html) — a reversal foreshadowed by Trump’s own collapsing approval numbers heading into the vote, as [covered earlier](https://rews.cc/a/gas-prices-push-trump-s-approval-to-truman-era-low-as-midter-0d0f3c). Cassidy himself lost his Louisiana primary in May and leaves the Senate in January; Bernie Sanders, HELP’s ranking Democrat, is set to take the chair. Any nominee Trump sends up now has weeks, not months, to clear a committee that is about to flip beneath him. The number worth watching next: zero new nominations filed so far, against two months left on the clock before Sanders runs the room.

## See also

- [United States Senate Committee on Health, Education, Labor, and Pensions](https://ballotpedia.org/United_States_Senate_Committee_on_Health,_Education,_Labor,_and_Pensions) — ballotpedia.org · Full roster and jurisdiction of the committee at the center of both votes
- [National Science Board](https://en.wikipedia.org/wiki/National_Science_Board) — en.wikipedia.org · Background on the 24-member body Trump dismissed entirely in April 2026
- [Federal Research and Development (R&D) Funding: FY2026](https://www.congress.gov/crs-product/R48694) — congress.gov · Congressional Research Service breakdown of enacted FY2026 science funding
- [White House withdraws nominee for FDA commissioner](https://www.npr.org/2026/11/18/nx-s1-6042516/white-house-withdraws-nominee-for-fda-commissioner) — npr.org · NPR's separate account of the Overton withdrawal
- [Senate panel vote on National Science Foundation nominee is abruptly pulled](https://www.washingtonpost.com/health/2026/11/18/senate-panel-vote-national-science-foundation-nominee-is-abruptly-pulled/) — washingtonpost.com · The Washington Post's account of the O'Neill vote being pulled
